155 related articles for article (PubMed ID: 31025390)
1. Distant metastasis due to heavily pigmented epithelioid melanoma with underlying BRAF V600E, NOTCH1, ERBB3, and PTEN mutations.
Motaparthi K; George EV; Guo R
J Cutan Pathol; 2019 Aug; 46(8):613-618. PubMed ID: 31025390
[TBL] [Abstract][Full Text] [Related]
2. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.
Cohen JN; Joseph NM; North JP; Onodera C; Zembowicz A; LeBoit PE
Am J Surg Pathol; 2017 Oct; 41(10):1333-1346. PubMed ID: 28796000
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
5. Pigmented Epithelioid Melanocytoma: Morphology and Molecular Drivers.
Benton S; Zhao J; Asadbeigi S; Kim D; Zhang B; Gerami P
Surg Pathol Clin; 2021 Jun; 14(2):285-292. PubMed ID: 34023106
[TBL] [Abstract][Full Text] [Related]
6. Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 Cases.
Isales MC; Mohan LS; Quan VL; Garfield EM; Zhang B; Shi K; Arva N; Beaubier N; Yazdan P; White K; Taxter TJ; Gerami P
Am J Surg Pathol; 2019 Apr; 43(4):480-488. PubMed ID: 30475255
[TBL] [Abstract][Full Text] [Related]
7. Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum: PRKAR1A Inactivation Can Occur in Different Genetic Backgrounds (Common, Blue, and Spitz Subgroups) With Variation in Their Clinicopathologic Characteristics.
de la Fouchardiere A; Tirode F; Castillo C; Buisson A; Boivin F; Macagno N; Pissaloux D
Am J Surg Pathol; 2022 Aug; 46(8):1106-1115. PubMed ID: 35319526
[TBL] [Abstract][Full Text] [Related]
8. Two congenital cases of pigmented epithelioid melanocytoma studied by fluorescent in situ hybridization for melanocytic tumors: case reports and review of these recent topics.
Battistella M; Prochazkova-Carlotti M; Berrebi D; Bennaceur S; Edan C; Riffaud L; Rütten A; Fraitag S
Dermatology; 2010; 221(2):97-106. PubMed ID: 20558976
[TBL] [Abstract][Full Text] [Related]
9. Synchronized Targeting of Notch and ERBB Signaling Suppresses Melanoma Tumor Growth through Inhibition of Notch1 and ERBB3.
Zhang K; Wong P; Salvaggio C; Salhi A; Osman I; Bedogni B
J Invest Dermatol; 2016 Feb; 136(2):464-472. PubMed ID: 26967479
[TBL] [Abstract][Full Text] [Related]
10. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA
Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523
[TBL] [Abstract][Full Text] [Related]
11. The role of gene fusions in melanocytic neoplasms.
Quan VL; Panah E; Zhang B; Shi K; Mohan LS; Gerami P
J Cutan Pathol; 2019 Nov; 46(11):878-887. PubMed ID: 31152596
[TBL] [Abstract][Full Text] [Related]
12. Vulvar Pigmented Epithelioid Melanocytoma With a Novel HTT-PKN1 Fusion: A Case Report.
Donati M; Kastnerova L; Cempírková D; Vaněček T; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Jul; 42(7):544-546. PubMed ID: 31972666
[TBL] [Abstract][Full Text] [Related]
13. Distinct sets of genetic alterations in melanoma.
Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
[TBL] [Abstract][Full Text] [Related]
14. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract][Full Text] [Related]
15. Pleural metastasis from auricular melanoma: A brief report.
Straccia P; Martini M; Pierconti F
Diagn Cytopathol; 2020 Apr; 48(4):376-379. PubMed ID: 31846216
[TBL] [Abstract][Full Text] [Related]
16. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
Goel VK; Lazar AJ; Warneke CL; Redston MS; Haluska FG
J Invest Dermatol; 2006 Jan; 126(1):154-60. PubMed ID: 16417231
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression.
Ehsani L; Cohen C; Fisher KE; Siddiqui MT
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):648-51. PubMed ID: 25046227
[TBL] [Abstract][Full Text] [Related]
19. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.
Zembowicz A; Carney JA; Mihm MC
Am J Surg Pathol; 2004 Jan; 28(1):31-40. PubMed ID: 14707861
[TBL] [Abstract][Full Text] [Related]
20. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
Fisher KE; Cohen C; Siddiqui MT; Palma JF; Lipford EH; Longshore JW
Hum Pathol; 2014 Nov; 45(11):2281-93. PubMed ID: 25228337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
